E. Ohman J:or Asset Management AB

Holdings History for AbbVie Inc. - Common Stock (ABBV)

Symbol: ABBV on NYSE
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.33%	+0.33%	$14,191,971	62,112	+62,112	NEW	$228.49	Q4 2025
31 Mar 2023		-1.6%	$0	0	-226,889	-100%	$223.26	Q1 2023
31 Dec 2022	1.6%	-0.2%	$36,667,531	226,889	-28,010	-11%	$161.61	Q4 2022
30 Sep 2022	1.6%	-0.06%	$34,209,995	254,899	-9,678	-3.7%	$134.21	Q3 2022
30 Jun 2022	1.8%	-0.06%	$40,522,613	264,577	-9,590	-3.5%	$153.16	Q2 2022
31 Mar 2022	1.5%	+1.3%	$44,445,212	274,167	+242,060	+754%	$162.11	Q1 2022
31 Dec 2021	0.13%	-0.18%	$4,347,288	32,107	-46,900	-59%	$135.40	Q4 2021
30 Sep 2021	0.27%	+0.01%	$8,522,485	79,007	+2,500	+3.3%	$107.87	Q3 2021
30 Jun 2021	0.27%	+0.02%	$8,617,748	76,507	+5,700	+8.1%	$112.64	Q2 2021
31 Mar 2021	0.28%	+0.14%	$7,662,734	70,807	+34,800	+97%	$108.22	Q1 2021
31 Dec 2020	0.16%	-0.01%	$3,858,150	36,007	-2,700	-7%	$107.15	Q4 2020
30 Sep 2020	0.17%	-0.01%	$3,390,346	38,707	-2,300	-5.6%	$87.59	Q3 2020
30 Jun 2020	0.23%	+0.04%	$4,026,067	41,007	+6,507	+19%	$98.18	Q2 2020
31 Mar 2020	0.19%	-0.02%	$2,628,555	34,500	-2,800	-7.5%	$76.19	Q1 2020
31 Dec 2019	0.18%	-0.14%	$3,302,542	37,300	-28,800	-44%	$88.54	Q4 2019
30 Sep 2019	0.32%	+0.01%	$5,005,092	66,100	+3,100	+4.9%	$75.72	Q3 2019
30 Jun 2019	0.3%	+0.01%	$4,581,360	63,000	+3,000	+5%	$72.72	Q2 2019
31 Mar 2019	0.33%	-0.02%	$4,835,400	60,000	-4,200	-6.5%	$80.59	Q1 2019
31 Dec 2018	0.43%	-0.06%	$5,918,598	64,200	-8,600	-12%	$92.19	Q4 2018
30 Sep 2018	0.45%	+0.04%	$6,885,424	72,800	+7,200	+11%	$94.58	Q3 2018
30 Jun 2018	0.43%	+0.13%	$6,077,840	65,600	+20,300	+45%	$92.65	Q2 2018
31 Mar 2018	0.34%	-0.02%	$4,287,645	45,300	-2,200	-4.6%	$94.65	Q1 2018
31 Dec 2017	0.37%	+0.04%	$4,593,725	47,500	+4,900	+12%	$96.71	Q4 2017
30 Sep 2017	0.34%	+0.02%	$3,785,436	42,600	+2,000	+4.9%	$88.86	Q3 2017
30 Jun 2017	0.3%	-0.02%	$2,943,906	40,600	-2,300	-5.4%	$72.51	Q2 2017
31 Mar 2017	0.34%	+0.04%	$2,795,364	42,900	+4,500	+12%	$65.16	Q1 2017
31 Dec 2016	0.33%	+0.03%	$2,404,608	38,400	+3,500	+10%	$62.62	Q4 2016
30 Sep 2016	0.33%	+0.02%	$2,201,143	34,900	+1,800	+5.4%	$63.07	Q3 2016
30 Jun 2016	0.34%	+0.03%	$2,049,221	33,100	+3,100	+10%	$61.91	Q2 2016
31 Mar 2016	0.31%	-0.03%	$1,713,600	30,000	-3,000	-9.1%	$57.12	Q1 2016
31 Dec 2015	0.34%	0%	$1,954,920	33,000	0		$59.24	Q4 2015
30 Sep 2015	0.48%	-0.04%	$1,795,530	33,000	-3,000	-8.3%	$54.41	Q3 2015
30 Jun 2015	0.57%	+0.04%	$2,418,840	36,000	+2,700	+8.1%	$67.19	Q2 2015
31 Mar 2015	0.45%	0%	$1,949,382	33,300	0		$58.54	Q1 2015
31 Dec 2014	0.53%	-0.04%	$2,207,790	33,300	-2,400	-6.7%	$66.30	Q4 2014
30 Sep 2014	0.5%	0%	$2,062,032	35,700	0		$57.76	Q3 2014
30 Jun 2014	0.49%	-0.04%	$2,014,908	35,700	-2,700	-7%	$56.44	Q2 2014
31 Mar 2014	0.49%	0%	$1,973,760	38,400	0		$51.40	Q1 2014
31 Dec 2013	0.48%	-0.03%	$2,035,584	38,400	-2,100	-5.2%	$53.01	Q4 2013
30 Sep 2013	0.46%	+0.03%	$1,811,565	40,500	+3,000	+8%	$44.73	Q3 2013
30 Jun 2013	0.43%	-0.06%	$1,550,250	37,500	-5,700	-13%	$41.34	Q2 2013
31 Mar 2013	0.47%	+0.47%	$1,761,696	43,200	+43,200	NEW	$40.78	Q1 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.